Why Is Kenvue Stock Rising Today?

2025-09-23 10:11:58

(MENAFN- AsiaNet News)

Kenvue (KVUE) shares jumped nearly 6% in premarket trading on Tuesday and became the top trending ticker on Stocktwits after Citigroup stated that it sees limited legal risk for the company following President Donald Trump's discouragement of pregnant women from taking Acetaminophen, the active ingredient in Tylenol.

Citi maintained a 'Neutral rating on the stock with a $20 price target, according to TheFly. Citi expects Kenvue shares to trade higher on Tuesday, following yesterday's selloff, given the lack of new scientific evidence presented by the Trump administration regarding Tylenol use.

Get updates to this developing story directly on Stocktwits.

For updates and corrections, email newsroom[at]stocktwits[dot]com.

MENAFN23092025007385015968ID1110099987

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.